Patents by Inventor Husseini Manji

Husseini Manji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230419850
    Abstract: Cognitive and mood states of a real world person are assessed according to activity in a virtual world environment with which the person interacts. The virtual world is configured to provide interactive experiences for assessing the person's cognitive and/or mood states. The system requires configuration of a session avatar during each virtual world session to provide then-current insight into the person's mood state. The system may require configuration of an avatar reflective of the person's state. The system requires the person to configure the virtual world environment during each virtual session to provide then-current insight into the person's mood state. The system permits the user to visit destinations, perform tasks and play games that are included in the environment for the purpose of providing insight into the person's cognitive and/or mood states according to the person's selections and/or performance.
    Type: Application
    Filed: March 27, 2023
    Publication date: December 28, 2023
    Applicant: Janssen Pharmaceutica NV
    Inventors: Joseph Barbuto, Katherine Bettencourt, Carine Brouillon, Gabriel Brun, Alexandra Kramer, Joe Manfredonia, Husseini Manji, Kenneth Mosca, Mark Sapp, Magdalena Schoeneich
  • Patent number: 11615713
    Abstract: Cognitive and mood states of a real world person are assessed according to activity in a virtual world environment with which the person interacts. The virtual world is configured to provide interactive experiences for assessing the person's cognitive and/or mood states. The system requires configuration of a session avatar during each virtual world session to provide then-current insight into the person's mood state. The system may require configuration of an avatar reflective of the person's state. The system requires the person to configure the virtual world environment during each virtual session to provide then-current insight into the person's mood state. The system permits the user to visit destinations, perform tasks and play games that are included in the environment for the purpose of providing insight into the person's cognitive and/or mood states according to the person's selections and/or performance.
    Type: Grant
    Filed: May 25, 2017
    Date of Patent: March 28, 2023
    Assignee: Janssen Pharmaceutica NV
    Inventors: Joseph Barbuto, Katherine Bettencourt, Carine Brouillon, Gabriel Brun, Alexandra Kramer, Joe Manfredonia, Husseini Manji, Kenneth Mosca, Mark Sapp, Magdalena Schoeneich
  • Publication number: 20200388178
    Abstract: Cognitive and mood states of a real world person are assessed according to activity in a virtual world environment with which the person interacts. The virtual world is configured to provide interactive experiences for assessing the person's cognitive and/or mood states. The system requires configuration of a session avatar during each virtual world session to provide then-current insight into the person's mood state. The system may require configuration of an avatar reflective of the person's state. The system requires the person to configure the virtual world environment during each virtual session to provide then-current insight into the person's mood state. The system permits the user to visit destinations, perform tasks and play games that are included in the environment for the purpose of providing insight into the person's cognitive and/or mood states according to the person's selections and/or performance.
    Type: Application
    Filed: May 25, 2017
    Publication date: December 10, 2020
    Applicant: Janssen Pharmaceutica NV
    Inventors: Joseph Barbuto, Katherine Bettencourt, Carine Brouillon, Gabriel Brun, Alexandra Kramer, Joe Manfredonia, Husseini Manji, Kenneth Mosca, Mark Sapp, Magdalena Schoeneich
  • Publication number: 20080102467
    Abstract: The invention provides a method of screening patients to identify those patients more likely to exhibit an increased risk of treatment-emergent suicidal ideation comprising: (a) obtaining a sample of genetic material from the patients, and (b) assaying the sample for the presence of a genotype in the patients which is associated with an increased risk of treatment-emergent suicidal ideation, wherein the genotype is characterized by a polymorphism in a gene selected from the group consisting of glutamine receptor, ionotropic, kainate 2 (GRIK2); glutamate receptor ionotropic AMPA 3 (GRIA3); and combinations thereof.
    Type: Application
    Filed: October 26, 2007
    Publication date: May 1, 2008
    Applicants: GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT., BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Francis McMahon, Gonzalo Laje, Silvia Paddock, Husseini Manji, A. John Rush
  • Publication number: 20070287753
    Abstract: Methods and compositions for the treatment of treatment-resistant depression are described. More specifically, the invention demonstrates that intranasal administration of ketamine is effective to ameliorate the symptoms of depression in a patient who has not responded to an adequate trial of one antidepressant in the current episode and has recurrent or chronic depressive symptoms (>2 years).
    Type: Application
    Filed: March 20, 2007
    Publication date: December 13, 2007
    Applicants: MOUNT SINAI SCHOOL OF MEDICINE, NATIONAL INSTITUTE OF HEALTH, YALE UNIVERSITY SCHOOL OF MEDICINE
    Inventors: Dennis Charney, Sanjay Mathew, Husseini Manji, Carlos Zarate, John Krystal